Navigation Links
Evotec Starts Phase II in Smoking Cessation with EVT 302
Date:2/28/2008

ination transaction involving Evotec and Renovis, including future financial and operating results, the combined company's plans, objectives, expectations and intentions, the anticipated timing and results of the combined company's clinical and preclinical programs, and other statements that are not historical facts. Evotec cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. These include risks and uncertainties relating to: the ability to obtain regulatory approvals of the transaction on the proposed terms and schedule; the parties' ability to complete the transaction because conditions to the closing of the transaction may not be satisfied; the failure to successfully integrate the businesses; unexpected costs or liabilities resulting from the transaction; the risk that synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; general worldwide economic conditions and related uncertainties; future legislative, regulatory, or tax changes as well as other economic, business and/or competitive factors; and the effect of exchange rate fluctuations on international operations. The risks included above are not exhaustive.

Contact:

Evotec AG

Anne Hennecke

SVP, Investor Relations & Corporate Communications

Phone: +49(0)40-56081-286

Fax: +49(0)40-56081-333

E-Mail: anne.hennecke@evotec.com


'/>"/>
SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
2. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
3. Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York
4. Evotec AG: R&D Update on 16 October 2007 Live on the Internet
5. Evotec Reports Third Quarter 2007 Results
6. Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board
7. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
8. Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
9. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Industry leaders ... to engage around the theme, ,Commercial Opportunities in the ...   Elsevier , a world-leading provider ... will host a gathering of some of the industry,s ... impacting healthcare today and in the future. The ...
(Date:9/30/2014)... Pacific Northwest Biotechnology, LLC - Product ... Markets Direct,s, ,Pacific Northwest Biotechnology, LLC - Product ... the Pacific Northwest Biotechnology, LLC,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Pacific ... various stages, therapeutics assessment by drug target, mechanism ...
(Date:9/30/2014)... Proove Biosciences , the commercial and research leader ... genetic test built upon research from their published P.A.I.N. ... provide physicians with an objective way to understand theirs ... between individuals. With this new test, physicians will be ... predisposition that will affect their pain tolerance. , The ...
(Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
Breaking Biology Technology:Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
... INDIANAPOLIS, Oct. 20, 2011 BioStorage Technologies, Inc. ... biomaterial storage and cold chain logistics for the ... Benchmarking Symposium at the International Contract Services Expo ... Germany. The symposium will include ...
... 2011 MiMedx Group, Inc.  (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... "Pete" Petit, has been inducted into the National Academy ... Academy of Engineering is among the highest professional distinctions ...
... Oct. 20, 2011 Med track is pleased ... 2011. Attendees of the show will be the first ... the newly designed platform. With deeply integrated datasets and ... professionals in business development, competitive intelligence and sales and ...
Cached Biology Technology:BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo 2MiMedx Group's Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering 2Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011 2
(Date:10/1/2014)... in the deserts, rainforests, prairies and forests of the ... City,s Central Park, according to a surprising new study ... Colorado Boulder. , The research team analyzed 596 ... and discovered a stunning diversity of below-ground life, most ... Only 8.5 percent to 16.2 percent of the organisms ...
(Date:9/30/2014)... Ill. --- Do we think of nature as something that ... we need to "preserve?" Or do we think of ourselves ... part of nature, but what about a house? , ... are also reflected in our actions, our speech and in ... with the University of Washington, the American Indian Center of ...
(Date:9/30/2014)... National Institutes of Health (NIH) awarded Lawrence Livermore ... an electrode array system that will enable researchers ... unprecedented resolution and scale. , LLNL,s grant-funded project ... Obama,s BRAIN (Brain Research through Advancing Innovative ... revolutionize our understanding of the human mind and ...
Breaking Biology News(10 mins):Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
... Dua, an assistant professor of computer science, and ... engineering, are using their skills and technical knowledge ... of Defense with sensor networks and tracking capabilities. ... Tracking, or ATR, involves the development of fast ...
... are multifactorial: they are not simply the result of ... that can no longer carry out its job. Diabetes ... and environmental factors. Similarly, in biotechnology, processes cannot be ... process. It is the networks of interaction that Systems ...
... a leading publisher of scientific, technical and medical ... than 4,000 eBooks on ScienceDirect. eBooks on ScienceDirect ... the present. These include scientific and technical books ... from renowned imprints including Pergamon and Academic Press. ...
Cached Biology News:Louisiana Tech researchers investigate tracking, sensors to assist Air Force 2Louisiana Tech researchers investigate tracking, sensors to assist Air Force 3Europe needs collective effort on System Biology, says ESF Task Force 2Europe needs collective effort on System Biology, says ESF Task Force 3Europe needs collective effort on System Biology, says ESF Task Force 44,000 e-Books now available on ScienceDirect 2
...
... and flexibility of the BDTM LSR, the first UV ... The BD LSR II has performance, capabilities, and ... Free up your high-performance cell sorter by moving your ... LSR II. The BD LSR II can be configured ...
... Flow Cytometer System is a full featured, two ... the C6 Flow Cytometer, CFlow Software, and a ... Cytometer System provides all the capabilities of the ... the price. The C6 Flow Cytometer System has ...
...
Biology Products: